Analystreport

Caladrius Biosciences Inc (NASDAQ: CLBS) had its price target raised by analysts at HC Wainwright to $15.00. They now have a "buy" rating on the stock.

Caladrius Biosciences, Inc.  (CLBS) 
Last caladrius biosciences, inc. earnings: 11/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: caladrius.com/investors/overview